Ashvita holds a master’s degree in Health Economics Policy and Law and a bachelor’s degree in Health Policy and Management from the Erasmus University Rotterdam. She wrote her master thesis about the cost-effectiveness of the drug alpelisib for advanced breast cancer in the Dutch setting. As a Research Associate, she supports health economic and evidence synthesis projects.